200 results on '"Moguilevsky N"'
Search Results
2. Functional Structure of the Secretin Receptor
3. Rational Drug Design Using Mammalian Cell Lines Expressing Site-Directed Mutants of the Human H1 Histaminic Receptor
4. Protective in Vivo Effect Against Murine Rickettsia Infection by Recombinant Myeloperoxidase Produced in CHO Cells
5. Recombinant Human Proapolipoprotein A-I: Experimental Strategies for the Production of an Authentic Molecule
6. The pleiotropic effect of statins in haemodialysis patients is not the consequence of an inhibition of LDL oxidation by myeloperoxidase
7. Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation
8. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions
9. Major role for the carboxylic function of cetirizine and levocetirizine in their binding characteristics to human H1-histamine-receptors
10. Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality☆
11. Lactoferrin Uptake by the Reticuloendothelial System of the Mouse Liver
12. Study of the Siderophores and Receptors in Different Clinical Isolates of Pseudomonas aeruginosa
13. Characterization of Recombinant Bovine Lactoperoxidase Produced by CHO Cells
14. Myeloperoxidase and its products in synovial fluid of patients with treated or untreated rheumatoid arthritis
15. Organic and inorganic substrates as probes for comparing native bovine lactoperoxidase and recombinant human myeloperoxidase
16. Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis
17. A comparison between native and recombinant forms of lactoperoxidase and myeloperoxidase by using organic and inorganic substrates as a probe
18. The sulfonium ion linkage in myeloperoxidase - Direct spectroscopic detection by isotopic labeling and effect of mutation
19. Difference fourier transform infrared evidence for ester bound linking the heme group in myeloperoxidase, lactoperoxidase, and eosinophil peroxidase
20. Antigens and granularity of blood monocytes in relation to inflammatory markers and lipids in postmenopausal women
21. Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation
22. Hypotheses for a re-evaluation of peroxidase activity in the oral inflammation: NAD(P)H-dependent hypohalite reduction in human neutrophils
23. MS140 EFFECTS OF COPPER AND MYELOPEROXIDASE-MODIFIED LDLS ON THE Nrf2 PATHWAY IN HUMAN ENDOTHELIAL CELLS UNDER STATIC AND SHEAR STRESS CONDITIONS
24. MS21 COPPER AND MYELOPEROXIDASE-MODIFIED LDLS ACTIVATE NRF2 THROUGH DIFFERENT PATHWAYS OF ROS PRODUCTION IN MACROPHAGES
25. P312 OXIDATION OF CYANIDE TO CYANATE BY MYELOPEROXIDASE: A NEW ROUTE FOR APOLIPOPROTEIN CARBAMYLATION?
26. TRYPTAMINE DERIVATIVES INHIBIT THE MYELOPEROXIDASE-DEPENDENT LDL OXIDATION
27. PO10-284 INHIBITION OF THE MPO/H2O2/CHLORIDE DEPENDENT LDL OXIDATION ASSESSED BY IN VITRO, ELISA AND CELL TESTS
28. Antigens and granularity of blood monocytes in relation to inflammatory markers and lipids in postmenopausal women
29. Sequences (103-110) and (116-120) of the Rat Secretin Receptor are Implicated in Secretin and VIP Recognition
30. Th-P15:141 Flufenamic acid and its 5-hydroxy-metabolite inhibit the specific oxidation of LDL by the myeloperoxidase/H2O2/CL-system
31. W12-P-080 Comparative assessment of the inhibiting effect of captopril and of 4 antagonists of the angiotensin converting enzyme on LDL oxidation by the myeloperoxidase
32. W12-P-089 Myeloperoxidase-modified (MOX) LDL induce the production of IL-8 by endothelial cells in contrast to MOX-albumin
33. Human recombinant myeloperoxidase antiviral activity on cytomegalovirus
34. Uptake of recombinant myeloperoxidase, free or fused to Fc gamma, by macrophages enhances killing activity toward micro-organisms.
35. Human recombinant myeloperoxidase antiviral activity on cytomegalovirus
36. Exposure of Macrophages to an Enzymatically Inactive Macrophage Mannose Receptor Ligand Augments KiIIing of Candida albicans
37. Phagocytosis and Intracellular Killing of Candida albicans by Macrophages Exposed to Myeloperoxidase
38. Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis
39. Exogenous myeloperoxidase enhances bacterial phagocytosis and intracellular killing by macrophages
40. Restricted Specificity of Anti-MPO Antibodies in Systemic Vasculitis: Implications for Therapy
41. Neutrophil-macrophage Interaction: a paradigm for chronic inflammation
42. Pharmacological and Functional Characterisation of the Wild—Type and Site—Directed Mutants of the Human H1Histamine Receptor Stably Expressed in CHO Cells
43. Site-Directed Mutagenesis of Human Myeloperoxidase: Further Identification of Residues Involved in Catalytic Activity and Heme Interaction
44. Virucidal effect of myeloperoxidase on human immunodeficiency virus type 1-infected T cells
45. Candidicidal activity of the human recombinant myeloperoxidase system
46. Spectral and enzymatic properties of human recombinant myeloperoxidase: Comparison with the mature enzyme
47. Sequences (103-110) and (116-120) of the Rat Secretin Receptor are Implicated in Secretin and VIP Recognition.
48. Pharmacological and Functional Characterisation of the Wild-Type and Site-Directed Mutants of the Human H1 Histamine Receptor Stably Expressed in CHO Cells.
49. Exposure of Macrophages to an Enzymatically Inactive Macrophage Mannose Receptor Ligand Augments Killing of Candida albicans
50. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs investigated with a human recombinant enzyme
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.